Cell-based Gene Therapy May Offer Long-term Treatment for Hemophilia A, Mouse Study Suggests

Cell therapy with endothelial progenitor cells and stem cells genetically engineered to produce a functional clotting factor VIII (FVIII) may provide a stable and long-term treatment for hemophilia A, a mouse study has found. Read the full story here.